This is a review about HLA-DQB1, based on 1 published articles, using HLA-DQB1 antibody in all methods. It is aimed to help Labome visitors find the most suited HLA-DQB1 antibody.
HLA-DQB1 synonym: CELIAC1; HLA-DQB; IDDM1; HLA class II histocompatibility antigen, DQ beta 1 chain; MHC DQ beta; MHC class II DQ beta chain; MHC class II HLA-DQ beta glycoprotein; MHC class II antigen DQB1; MHC class II antigen HLA-DQ-beta-1; MHC class2 antigen; lymphocyte antigen

gallery
Leica Microsystems
  • immunohistochemistryIn 2007, Cheng Shyong Chang et al. applied Leica Microsystems HLA-DQB1 antibody to perform immunohistochemistry in order to show CD80 and CD86 may be potential nasopharyngeal carcinoma markers for clinical outcome [ncbi , more , fig ].
Figure
Novocastra Laboratories anti-HLA Class II (DR) was used to perform immunohistochemistry in order to show CD80 and CD86 may be potential nasopharyngeal carcinoma markers for clinical outcome.
HLA-DQB1 antibody immunohistochemistry Leica Microsystems
Positive membrane staining of HLA-DR in undifferentiated carcinoma, 400 x (left); negative staining of HLA-DR in carcinoma cellsand dispersed lymphocytes with HLA-DR expression, 400 x (right).
Cheng Shyong Chang et al. (2007). "Expression of CD80 and CD86 costimulatory molecules are potential markers for better survival in nasopharyngeal carcinoma".PMID 17524139
Articles Reviewed
  1. Cheng Shyong Chang et al. (2007). "Expression of CD80 and CD86 costimulatory molecules are potential markers for better survival in nasopharyngeal carcinoma".PMID 17524139